This study was designed to characterize the phenolic profile and evaluate the antibacterial, antimutagenic and antitumor activities of Veronica urticifolia Jacq. methanolic extract.
Introduction
Cancer, the second leading cause of death worldwide next to cardiovascular diseases, is a group of more than 100 different diseases, characterized by uncontrolled cellular growth, local tissue invasion and distant metastases (Madhusudan and Middleton, 2005) . According to World Health Organization, more than 10 million new cases of cancer are diagnosed every year, and the statistical trends indicate that this number would double by 2020 (Mignogna et al., 2004) . The demand for new anticancer agents is escalating due to the accumulation of carcinogenic and mutagenic agents in the environment. Although many synthetic anticancer agents are used in the treatment of cancer, side effects and emergence of synthetic drug resistant cancer cells among patients limits their purpose (Madhusudan and Middleton, 2005) .
Recent studies have shown that cancer management by phytochemicals from vegetables, fruits and medicinal plants is one of the most feasible approaches to treat this cascading disease (Dhamija et al., 2013) .
In the fight against cancer, the search for antimutagenic agents is essential, since mutagenic and carcinogenic factors are present in the human environment and their total elimination seems to be impossible (Abdillahi et al., 2012) . Humans are provided with many defences and their failure could lead to DNA damage and consequently to cancer (El-Sayed and Hussin, 2013) . Carcinogenesis is generally a slow process and often takes decades from tumor initiation to diagnosis, offering a considerable time frame for chemopreventive approaches.
Chemoprevention is defined as the use of specific natural or synthetic agents to prevent, delay, or slow the carcinogenic process (Martin et al., 2013) . The prevention of cancer can be achieved by avoiding exposures to mutagens, by fortifying physiological defence mechanisms, or by supplying the intake of protective factors (De Flora, 1998) . Human epidemiology and animal studies have indicated that cancer risk may be modified by changes in dietary habits or by dietary supplements (Miyazawa and Hisama, 2004) .
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More than 15% of malignancies worldwide are established to have an infectious cause (Mager, 2006) . Therefore, application of methods to prevent and/or treat infection, such as the use of antimicrobial treatments, could have an effect on future burden of cancer worldwide.
Although antibiotics decreased the spread and severity of a wide variety of infectious diseases, bacteria and fungi have developed numerous mechanisms to escape old and new antimicrobial agents due to their uncontrolled use. In this concern, the proper treatment of cancer and microbial infections would have a great impact on the population's health (Assaf et al., 2013) .
The identification of dietary components as potential cancer chemopreventive agents in the form of functional foods or as nutraceuticals has become an essential subject of many studies.
One of the best approaches in search for anticancer agents from plant resources is the selection of plant species based on ethnomedical leads and testing the selected species efficacy in light of modern science.
In traditional medicine, several Veronica species are used to treat cancer (Harput et al., 2002a) . As currently circumscribed, Veronica (Plantaginaceae) is a genus of 450 species found in temperate regions of both hemispheres. Regardless of widespread use, mostly as diuretics, for their wound-healing properties and in medical treatment of respiratory diseases, there is a scarcity of physiological evidence to support any claim of therapeutic values for Veronica species. Only few studies confirm that certain Veronica genus reveal considerable bioactivity such as antibacterial (Stojković et al., 2013; Gusev et al., 2012) , antioxidant (Živković et al., 2012) , anti-inflammatory (Harput et al., 2002a) and cytotoxic (Harput et al., 2002a; Saracoglu and Harput, 2012) activities.
On the other hand, the phytochemistry of the genus has been extensively studied with many species surveyed for their iridoid (Jensen et al., 2005) and phenylethanoid derivatives 5 (Taskova et al., 2006) and flavonoid glycosides (Albach et al., 2003 (Albach et al., , 2005 Saracoglu et al., 2004; Taskova et al., 2008) with most of these being considered beneficial for human health.
Previously we reported in vitro and in vivo antioxidant activity of Veronica urticifolia Jacq. (Živković et al., 2012) . Nevertheless, to the best of our knowledge, there are no reports on other biological activities of the selected species. Phenolic profile of the species V. urticifoila is presented for the first time. The aim of this study was profiling the phenolic compounds of V. urticifolia and evaluating the antibacterial, antimutagenic and antitumor effects of its methanolic extract.
Materials and methods

Plant samples
The aerial parts of Veronica urticifolia were collected during their flowering period in June 2008 from Mountain Goč in central Serbia. Plant material was taxonomically determined and deposited in the Herbarium collection of the Institute of Botany, School of Pharmacy, Belgrade (voucher specimen numbers were VR 165).
Standards and reagents
HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany).
Dimethylsulfoxide (DMSO) (Merck KGaA, Germany) was used as a solvent in antimicrobial assays. Formic acid was purchased from Prolabo (VWR International, France). N-acetyl-Lcysteine and Trypan blue solution were obtained from Sigma-Aldrich (Steinheim, Germany).
Nitroquinoline-N-oxide (4NQO) was purchased from Sigma, USA. The phenolic compound standards were from Extrasynthese (Genay, France). Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, USA). For biological activity evaluations, the air dried plant material was reduced to a fine powder and extracted by maceration with methanol in a solid/solvent ratio of 1:20 at room temperature for 48 h. The obtained extract was evaporated under reduced pressure and further kept in a vacuum desiccator to remove traces of solvents.
Elucidation of phenolic compounds structures
The extracts were analysed using a Hewlett-Packard 1100 chromatograph (Agilent Technologies) with a quaternary pump and a diode array detector (DAD) coupled to an HP Chem Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-2 C 18 , 3 µm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient established was isocratic 15% for 5 min, 15% B to 20% B over 5 min, 20-25% B over 10 min, 25-35% B over 10 min, 35-50% for 10 min, and re-equilibration of the column, using a flow rate of 0.5 mL/min; the injection volume was 100 µL. Double online detection was carried out in the DAD using 280 7 nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) connected to HPLC system via the DAD cell outlet.
MS detection was performed in an API 3200 Qtrap (Applied Biosystems, Darmstadt, Germany) equipped with an ESI source and a triple quadrupole-ion trap mass analyzer that was controlled by the Analyst 5.1 software. Zero grade air served as the nebulizer gas (30 psi) and turbo gas for solvent drying (400 ºC, 40 psi). Nitrogen served as the curtain (20 psi) and collision gas (medium). The quadrupols were set at unit resolution. The ion spray voltage was set at -4500 V in the negative mode. The MS detector was programmed to perform a series of two consecutive modes: enhanced MS (EMS) and enhanced product ion (EPI) analysis. EMS was employed to record full scan spectra to obtain an overview of all of the ions in sample. 
Antibacterial activity
Microdilution method.
The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were determined by the modified microdilution method (Espinel-Ingroff, 2001 ). Briefly, fresh overnight culture of bacteria was adjusted to a concentration of 1×10 5 CFU/mL by counting the spores in suspension. The inocula were prepared daily and stored at +4 ºC until use.
Dilutions of inocula were cultured on solid medium to verify the absence of contamination and check the validity of the inoculum. Different solvent dilutions of methanolic extract were carried out over the wells containing 100 µL of Tryptic Soy Broth (TSB) and afterwards, 10 µL of inoculum was added to all the wells. The microplates were incubated for 24 h1 at 37
ºC. The MIC of the samples was detected following the addition of 40 µL of iodonitrotetrazolium chloride (INT) (0.2 mg/mL) and incubation at 37 °C for 30 min. MBC was determined by serial sub-cultivation of 10 µL into microplates containing 100 µL of TSB.
The lowest concentration that shows no growth after this sub-culturing was read as the MBC. Streptomycin (Sigma P 7794) (0.05-3 mg/mL) was used as positive control for bacterial inhibition. A 5% solution of DMSO in water was used as negative control.
Antimutagenicity
A variation of the Ames test was used to screen for antimutagenic activity of Veronica urticifolia methanolic extract. For this activity, Salmonella typhimurium TA100 (Molecular Toxicology, Inc) without S9 metabolic activation were used due to cost implications. It is also known that these two strains are capable of identifying up to 90% of the mutagens (Mortelmans and Zeiger, 2000) . Here, 500 µL of 0.1 M phosphate buffer was added to 50 µL of test sample in a test-tube. Fifty microlitres of the nitroquinoline-N-oxide (4NQO) in DMSO (20 µg/mL) was added to the mixture and then pre-incubated for 3 min before the addition of 100 µL of overnight TA100 strains of bacterial culture. After incubation for 48 h at 37 °C, the number of viable cells (cultured on MH) and revertant colonies were determined (on minimal glucose agar) and percentage of inhibition (Index of antimutagenicity) calculated using the formula shown below. The extract was tested in triplicate and it was repeated twice. The percentage inhibition was calculated by the following formula: Percent of inhibition (%) = (1 -T/M) × 100, where T is the number of revertants per plate in the presence of the mutagen 4NQO, and M is the number of revertants per plate in the positive control (mutagen).
The mutagenic index (MI) was also calculated for each concentration tested, this being the average number of revertants per plate with the tested extract divided by the average number of revertants with the negative (solvent) control. A tested extract was considered mutagenic when a dose-response relationship was detected and a two-fold increase in the number of mutants (MI≥2) was observed for at least one concentration (Resende et al., 2012) .
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Cell viability was also determined to assess the potential bactericidal effect of the mutagens.
A substance was considered bactericidal when the bacterial survival was less than 60% of that observed in the negative control (Resende et al., 2012) . 
Cytotoxic activity against Ehrlich
Statistical analysis
All data are presented as mean ± standard deviations. One way analysis of variance (ANOVA) was used to detect any significant differences among different means as well as interactions between the variables used in biochemical analyses. Statistically significant effects were further analyzed and means were compared using Bonferroni test. A level of p<0.05 was taken as statistically significant.
Results and Discussion
Phenolic compounds characterization
The characterization of the phenolic compounds was performed by HPLC-DAD-ESI/MS analysis, and data of the retention time, λ max , pseudomolecular ion, main fragment ions in MS 2 , tentative identification and concentration of phenolic acid derivatives and flavonoids are presented in Table 1 . The HPLC phenolic profile recorded at 280 nm can be observed in Figure 1A . 
UV and mass spectra obtained by HPLC-DAD-ESI/MS
Hydroxycinnamoyl derivatives.
These compounds correspond to caffeic (peaks 1-4, 6-8 and 10 in residues were observed suggested that the two sugars were constituting a disaccharide (e.g., rutinose or neohesperidose), although the actual nature of the sugar residues could not be established from the MS analysis. Thus, the compounds were tentatively assigned as as caffeoyl deoxyhexosyl-hexosides I and II. observed for peak 10, suggesting that both compounds were isomers; they were tentatively assigned as acteoside and isoacteoside, respectively, based on their relative elution order according to Li et al. (2005) . Peak 7 corresponds to the majority (14.9 mg/g extract) phenolic compound in V. urticifolia extract. In fact, acteoside is a phenylethanoid glycoside, a group of phenolic compounds that is widely distributed in plants and was previously reported in Veronica species (Harput et al., 2002b; Johansen et al., 2007; Crişan et al., 2007) , being inclusively considered as an important chemotaxonomic marker. The detected amounts of acteoside highlight V. urticifolia as a potential natural source of this bioactive compound, already reported as having antimicrobial (Avila et al., 1999) , antigenotoxic (Zaabat et al., 2011) and antitumor (Ohno et al., 2002) properties.
Finally, peak 11 had a molecular ion [M-H] -at m/z 437 that produced an MS 2 base peak at m/z 163 ([coumaric acid-H] -), which linked to its UV spectrum (λ max at 312 nm) allowed to assign it to an unidentified coumaric acid derivative.
Flavones.
Flavones were the only detected flavonoids in V. urticifolia extracts ( Table 1) together with another ion at m/z 285 that might be due to the further loss of a methyl residue (-14 mu). These characteristics suggested that it could be a methyl derivative of luteolin, e.g., as chrysoeriol (3'-methyl-luteolin) or diosmetin (4'-methyl-luteolin), although its actual identity could not be established. Thus, the peak was tentatively assigned as a methyl-luteolin hexoside. Its elution order after peak 9 is also coherent with the loss of the polarity induced by the additional methyl group.
Antibacterial activity
The results of antibacterial activity of V. urticifolia methanolic extract and standard antibiotic streptomycin, tested by microdilution assay, are presented in Table 2 . Staphylococcus aureus was the most sensitive species with equal values of MIC and MBC of 7.5 mg/mL. The antibacterial activity of acteoside, the main phenolic compound, has already been 15 demonstrated in various studies. According to Avila et al. (1999) acteoside induced lethal effect on S. aureus by affecting protein synthesis and inhibiting leucine incorporation. As a result of these findings, activity of V. urticifolia methanolic extract against S. aureus could be attributed at least in part to acteoside. Nevertheless, other constituents of the extract should be taken into consideration for the global activity, e.g., the high amounts of apigenin and especially luteolin glycosides.
An overwhelming body of evidence has determined the association among certain bacteria and cancer (Mager, 2006) . Bacteria have been linked to cancer by two mechanisms: induction of chronic inflammation and production of carcinogenesis. The staphylococcal α-toxin has been shown to activate both several cytokines which have been linked to all steps in tumor development and nuclear factor κB, known tumor promoter in the development of hepatocellular carcinoma (Kullander et al., 2009 ).
Micrococcus flavus, Listeria monocytogenes and Enterococcus faecalis were similarly
susceptible to the inhibitory (MIC = 7.5 mg/mL) and bactericidal (MBC = 15 mg/mL) effects of the extract. The most resistant species were Bacillus cereus, Pseudomonas aeruginosa and Escherichia coli with MIC = MBC = 15 mg/mL. As shown in Table 2 , streptomycin has stronger activity than tested extract. The obtained results for antibacterial activity are comparable to those published previously for V. montana water extract (Stojkovic et al., 2013) .
Antimutagenicity testing
As mutations are known to be the most important cause of the initiation of many diseases, phytochemicals exhibiting antimutagenic potential could be of immense significance . It has been suggested that the use of antimutagen in daily life will be the most effective procedure for preventing human cancer and genetic disease (Bhagavathy et al., 16 2011). Antimutagenic compounds (e.g. carotenoids) interfere with mutagen metabolism, they may act as mutagen scavengers, or they may also inhibit either the initiation or promotion phase of the carcinogenic process (Bhagavathy et al., 2011) . Although an antimutagenic effect found in a plant extract does not necessarily mean that it is an anticarcinogen, it is however an indication of the possibility of acting as one (Abdillahi et al., 2012) . The Ames Salmonella test is widely accepted short-term bacterial assay for identifying substances that can produce genetic damage that leads to gene mutations. The test uses Salmonella strains with preexisting mutations that leave the bacteria unable to synthesize the required amino acid, histidine, and therefore unable to grow and form colonies in its absence. New mutations at the site of these pre-existing mutations, or nearby in the genes, can restore the gene's function and allow the cells to synthesize histidine. These newly mutated cells can grow in the absence of histidine and form colonies (Mortelmans and Zeiger, 2000) .
Lesions to DNA resulting from attack by reactive oxygen species (ROS) can be a major cause of mutagenesis and carcinogenesis (Mimica-Dukić et al., 2010) . Therefore, antioxidants may act as universal antimutagenic agents (Ananthi et al., 2010) . In a previous research, we demonstrated the protective role of methanolic extract of V. urticifolia in oxidative stress helping to keep normal levels of enzymatic and non-enzymatic antioxidants and lipid peroxidation (Živković et al., 2012) . Based on this, we extent our evaluation using the Ames Salmonella test.
In this study, the mutagenicity of V. urticifolia methanolic extract against S. typhimurium TA 100 was measured by comparing the ratio of induced revertants and spontaneous revertants in plates. According to Table 3 , the mutagenicity index showed that tested extract in the range 0.2-1 mg/plate, did not induce increase in the number of revertant colonies relative to the negative control, indicating the absence of any mutagenic activity.
As reported in Table 3 , tested extract displayed protective effects against 4-NQO induced mutagenicity. In determining the antimutagenic potential of a sample, a value smaller than 25% inhibition of the mutagen activity indicates a weak or non-antimutagenic effect, a moderate effect when the value is between 25 and 40% and strong antimutagenicity when the value is greater than 40% (Negi et al., 2003) . In the present study induced inhibition was dose dependent: 0.2 mg/plate and 0.5 mg/plate induced moderate antimutagenic activity reducing histidine-prototrophic revertant colonies by 25.8% and 36.2%, respectively. At 1 mg/plate the extract showed strong inhibitory effect against direct-acting mutagen 4NQO (inhibition rate was 48.3%). Since the extract plus bacterial strain treated plate did not produce any change in the background growth of bacteria with respect to the plate used to detect the spontaneous revertant, the antimutagenic activity of extract cannot be correlated to its toxicity to bacterial strains.
The exhibited antimutagenic activity of the extract might be ascribed to its constituents, in particular to the major phenolic compounds (acteoside and luteolin-O-glucuronide) polyphenols. In fact, some phenylpropanoids act as potent antimutagenic and anticarcinogenic agents (Miyazawa and Hisama, 2003) . According to Zaabat et al. (2011) acteoside showed pronounced antigenotoxic effect. Therefore, taking into consideration the concentration of acteoside in the extract, it can be suggested that acteoside could be an essential compound for the antimutagenic activity of V. urticifolia.
Keeping in prospect our previous publication regarding the antioxidant activity of tested extract, the exhibited antimutagenic activity might also be partially ascribed to its antioxidant activity.
Cytotoxic activity against Ehrlich's tumor cells in mice
Plants belonging to the genus Veronica and several of their constituents have shown potent cytotoxic activity on different cell lines (Harput et al., 2002a; Teng et al., 2008; Saracoglu and Harput, 2012) . In the present study the V. urticifolia methanolic extract was evaluated for its in vivo antitumor properties.
The Ehrlich tumor was initially described as a spontaneous murine mammary adenocarcinoma. It is a rapidly growing carcinoma with very aggressive behaviour. After Antitumor properties of V. urticifolia methanolic extract were assessed by parameters such as ascites volume, tumor cell count and cell viability; the results are shown in Table 4 . A single dose of tested extract was chosen since the preliminary results using different doses (0.2; 0.5; 1.0; 1.5 and 2.0 mL/kg b.w.) indicated that 2.0 mg/kg b.w. was the most effective dose. For the purpose of preliminary elucidation i.p. administration of the extract prior to oral application was chosen, in order to avoid possible chemical changes upon oral consumption of the extract.
The Ehrlich ascitic tumor implantation induces per se a local inflammatory reaction, with increasing vascular permeability, which results in an intense edema formation, cellular migration and progressive ascitic fluid formation (Agrawal et al., 2011) . The ascitic fluid is essential for tumor growth, since it constitutes a direct nutritional source for tumor cells (De Matos Gomes et al., 2008) . Our data showed that administration of NALC significantly reduced the ascitic fluid volume. On the other hand, after application of V. urticifolia methanolic extract the ascites volume became slightly decreased, but not to a statistically significant extent.
Ascites fluid accumulation occurs in parallel with the proliferation of tumor cells (Ozaslan et al., 2011) . Cytotoxic activity can be determined as a decreased-cell number because of cell death, while cell-growth inhibitory or cytostatic activity can be determined as a suppression of the increase of cell number without causing cell death. Administration of NALC or investigated extract during the course of this experiment led to slight, but insignificant reduction of number of tumor cells in peritoneal cavity as compared to control group, pointing to their oncostatic activity.
Prolongation of survival is directly related to decrease in viable cell count (Agrawal et al., 2011) . In the present study a significantly decreased EAC cell viability after administration of the tested extract in comparison to the control group was observed. Administration of the NALC showed no effect on tumor cell viability.
In conclusion, the observed antibacterial, antimutagenic and oncostatic effects of V. urticifolia methanol extract indicates that this species may play a role as a cancer-preventing agent. The effect can be partially ascribed to the phenolic compounds identified in the extract.
Nevertheless, further studies are needed to explain the role of phytochemicals in the bioactivities of V. urticifolia. The UV spectrum of the dominant compound (acteoside) is also shown (B).
